Munich - Delayed Quote EUR

Legend Biotech Corp (9LB.MU)

25.60
0.00
(0.00%)
As of 8:00:14 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
728,303
627,241
285,143
117,005
68,826
Cost of Revenue
251,186
234,581
144,214
65,363
0
Gross Profit
477,117
392,660
140,929
51,642
68,826
Operating Expense
713,143
695,903
580,414
507,262
461,113
Operating Income
-236,026
-303,243
-439,485
-455,620
-392,287
Net Non Operating Interest Income Expense
38,189
39,589
32,693
-2,614
71
Other Income Expense
362
105,521
-113,326
12,510
-14,980
Pretax Income
-197,475
-158,133
-520,118
-445,724
-407,196
Tax Provision
20,674
18,893
-1,864
625
-3,614
Net Income Common Stockholders
-218,149
-177,026
-518,254
-446,349
-403,582
Diluted NI Available to Com Stockholders
-218,149
-177,026
-518,254
-446,349
-403,582
Basic EPS
-1.18
-0.96
-2.94
-2.80
-2.74
Diluted EPS
-1.18
-0.96
-2.94
-2.80
-2.74
Basic Average Shares
183,290.50
182,851.07
176,082.71
159,041.96
140,851.65
Diluted Average Shares
183,290.50
182,851.07
176,082.71
159,041.96
140,851.65
Total Expenses
964,329
930,484
724,628
572,625
461,113
Net Income from Continuing & Discontinued Operation
-218,149
-177,026
-518,254
-446,349
-403,582
Normalized Income
-217,561.24
-259,915.17
-433,507.35
-463,336.37
-397,437.80
Interest Income
59,390
61,204
54,487
8,182
971
Interest Expense
21,201
21,615
21,794
10,796
900
Net Interest Income
38,189
39,589
32,693
-2,614
71
EBIT
-176,274
-136,518
-498,324
-434,928
-406,296
EBITDA
-153,438
-113,159
-477,873
-416,536
-392,379
Reconciled Cost of Revenue
251,186
234,581
144,214
65,363
0
Reconciled Depreciation
22,836
23,359
20,451
18,392
13,917
Net Income from Continuing Operation Net Minority Interest
-218,149
-177,026
-518,254
-446,349
-403,582
Total Unusual Items Excluding Goodwill
-744
104,923
-85,087
21,503
-6,200
Total Unusual Items
-744
104,923
-85,087
21,503
-6,200
Normalized EBITDA
-152,694
-218,082
-392,786
-438,039
-386,179
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-156.24
22,033.83
-340.35
4,515.63
-55.80
12/31/2021 - 9/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PRTCl.XC
 
4880.T CellSource Co., Ltd.
629.00
-1.10%
 
1GDA.F Zevra Therapeutics, Inc.
7.45
-1.32%
 
048410.KQ Hyundai Bioscience Co., Ltd.
11,230.00
-0.62%
 
DEX.ST DexTech Medical AB
5.95
+10.19%
 
BLUE.MX bluebird bio, Inc.
80.00
0.00%
 
VSC.BE 4SC AG
1.5850
+5.67%
 
4565.T Nxera Pharma Co., Ltd.
818.00
+1.74%
 
8EM.F Editas Medicine, Inc.
1.3785
+8.12%
 
KDEV.ST Karolinska Development AB (publ)
0.9760
-1.81%